Institution · EyePoint Pharmaceuticals (United States)

Most cited papers from EyePoint Pharmaceuticals (United States)

EyePoint Pharmaceuticals (United States)

What are the most cited papers from EyePoint Pharmaceuticals (United States)?

The most cited paper from EyePoint Pharmaceuticals (United States) is "Prevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers" (Lere Bao, Amy L. Kimzey, Guido Sauter et al., 2004), with 378 citations. Next come "Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial" (208) and "Sustained Delivery Fluocinolone Acetonide Vitreous Implants" (157).

Published FieldAccessCitations

Showing 37 of 37 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Prevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers Lere Bao, Amy L. Kimzey, Guido Sauter et al. · American Journal Of Pathology Open access	May 2004	378
2	Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial P. Andrew Pearson, Timothy L. Comstock, Michael S. Ip et al. · Ophthalmology	Aug 2011	208
3	Sustained Delivery Fluocinolone Acetonide Vitreous Implants José Guilherme Cunha-Vaz, Paul Ashton, Raymond Iezzi et al. · Ophthalmology Open access	16 Jun 2014	157
4	Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment Glenn J. Jaffe, Charles Stephen Foster, Carlos Eduardo Pavesio et al. · Ophthalmology Open access	24 Oct 2018	104
5	Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis Glenn J. Jaffe, Phoebe Lin, Robert T. Keenan et al. · Ophthalmology	16 Jul 2016	61
6	Intravitreous Delivery of the Corticosteroid Fluocinolone Acetonide Attenuates Retinal Degeneration in S334ter-4 Rats Inna V. Glybina, Alexander Kennedy, Paul Ashton et al. · Investigative Ophthalmology & Visual Science Open access	19 Mar 2010	52
7	Photoreceptor Neuroprotection in RCS Rats via Low-Dose Intravitreal Sustained-Delivery of Fluocinolone Acetonide Inna V. Glybina, Alexander Kennedy, Paul Ashton et al. · Investigative Ophthalmology & Visual Science	23 Sep 2009	50
8	Successful Treatment Strategies in Granulomatosis With Polyangiitis-Associated Peripheral Ulcerative Keratitis Nazanin Ebrahimiadib, Bobeck S. Modjtahedi, Ramak Roohipoor et al. · Cornea	4 Jul 2016	44
9	Fluocinolone Inhibits VEGF Expression via Glucocorticoid Receptor in Human Retinal Pigment Epithelial (ARPE-19) Cells and TNF-α–Induced Angiogenesis in Chick Chorioallantoic Membrane (CAM) Surya P. Ayalasomayajula, Paul Ashton, Uday B. Kompella · Journal of Ocular Pharmacology and Therapeutics	14 Mar 2009	43
10	Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm Raquel E. Reinbolt, Stephen T. Sonis, Cynthia Dawn Timmers et al. · Cancer Medicine Open access	23 Nov 2017	32
11	Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects Sophie J. Bakri, Jeff Lynch, Michelle Howard-Sparks et al. · PLoS ONE Open access	4 Jun 2024	24
12	Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration Sunil S. Patel, Philip P. Storey, Mark Barakat et al. · Ophthalmology Science Open access	9 Apr 2024	19
13	P4‐348: Evp‐6124: Safety, Tolerability And Cognitive Effects Of A Novel A7 Nicotinic Receptor Agonist In Alzheimer's Disease Patients On Stable Donepezil Or Rivastigmine Therapy Dana C. Hilt, Maria S. Gawryl, Gerhard Koenig et al. · Alzheimer s & Dementia Open access	Jul 2009	18
14	Safety Assessment of Subconjunctivally Implanted Devices Containing Latanoprost in Dutch-Belted Rabbits Bart A. Jessen, Michael H.I. Shiue, Harjeet Kaur et al. · Journal of Ocular Pharmacology and Therapeutics	14 Mar 2013	15
15	Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases Charles C. Wykoff, Baruch D. Kuppermann, Carl D. Regillo et al. · Journal of VitreoRetinal Diseases Open access	22 Aug 2024	13
16	Comparative analysis of PD ‐1 target engagement of dostarlimab and pembrolizumab in advanced solid tumors using ex vivo IL ‐2 stimulation data Daren J. Austin, Murad R. Melhem, Yash Pragnesh Gandhi et al. · CPT Pharmacometrics & Systems Pharmacology Open access	Nov 2022	11
17	IgA Nephropathy as the Initial Presentation of Celiac Disease in an Adolescent Stuart F. Slavin · PEDIATRICS Open access	9 Sep 2021	8
18	Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysis Cynthia Matossian, John A. Hovanesian, Jason Bacharach et al. · Journal of Cataract & Refractive Surgery Open access	11 Aug 2020	8
19	A Model of Cystitis Pain in the Mouse Liza Leventhal, Brian W. Strassle · Current Protocols in Pharmacology	Dec 2008	7
20	Evaluation of extended release brimonidine intravitreal device in normotensive rabbit eyes Sunil P. Deokule, Judit Baffi, Hongshuang Guo et al. · Acta Ophthalmologica Open access	7 Jun 2012	6
21	Dexamethasone intraocular suspension 9% in the capsular bag Robert H. Osher, Robert J. Weinstock · Journal of Cataract & Refractive Surgery	10 Dec 2020	4
22	First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery Jason Bacharach, Cathleen McCabe, Mitchell A. Jackson et al. · Clinical ophthalmology Open access	Jun 2022	3
23	P1‐219: GSM treatment after the onset of Aβ deposition in mice reduces total Aβ load Dorothy G. Flood, Angela Chien-Yu Chen, Rachelle Driscoll et al. · Alzheimer s & Dementia	Jul 2012	3
24	Minimizing Recurrences of Ocular Inflammation and Need for Adjunctive Treatment of Non-infectious Posterior Uveitis (NIPU) during the 2 Years Following Treatment with a Single 0.18 mg Fluocinolone Acetonide Intravitreal Insert (FAi) Quan Dong Nguyen, Keyur D. Patel, Dario A. Paggiarino et al. · Investigative Ophthalmology & Visual Science Open access	22 Jul 2019	2
25	Controlling Posterior Segment Uveitic Recurrences: Results from a Phase 3 Study of 0.18 mg Fluocinolone Acetonide Intravitreal Insert (FAi) in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment Quan Dong Nguyen, Keyur D. Patel, Dario A. Paggiarino · Investigative Ophthalmology & Visual Science Open access	13 Jul 2018	2
26	An Injectable Fluocinolone Acetonide Intravitreal Insert Decreases the Incidence of Recurrence in Patients with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye: 12 Month Results Glenn J. Jaffe, Dario A. Paggiarino, Gerald Riedel · Investigative Ophthalmology & Visual Science Open access	23 Jun 2017	2
27	P3–283: EVP‐6124, an alpha7 nicotinic acetycholine receptor partial agonist, did not delay cardiac repolarization in healthy subjects Gordon R. Loewen, Maria S. Gawryl, Ralph Schutz et al. · Alzheimer s & Dementia Open access	Jul 2013	2
28	P4‐279: Compound Screening In A Drosophila melanogaster Alzheimer's Disease Model Using A Behavioral Readout Matt B. Mahoney, Carol M. Singh, Lenard T. Diggins et al. · Alzheimer s & Dementia	Jul 2009	2
29	Treatment Options for Diabetic Macular Edema Anshul Bhatnagar, Daniel Shu Wei Ting, Christina Y. Weng · International Ophthalmology Clinics	26 Dec 2023	1
30	P3–282: Population pharmacokinetic modeling of EVP‐6124 following oral administration Steve Kuan, Gordon R. Loewen, Maria S. Gawryl et al. · Alzheimer s & Dementia	Jul 2013	1
31	Outcomes of very delayed onset chronic postoperative endophthalmitis caused by Cutibacterium acnes including treatment with endolaser photocoagulation Danny A. Mammo, Phuoc-Hanh D. Le, Sruthi Arepalli et al. · Journal of Cataract and Refractive Surgery Online Case Reports Open access	28 Oct 2022	0
32	PSivida corporation. Brian Leedman · PubMed	2008	0
33	Fluocinolone Acetonide-Mediated Neuroprotection in S334-ter-4 Rat Retinal Degeneration Raymond Iezzi, Inna V. Glybina, Alexander Kennedy et al. · Investigative Ophthalmology & Visual Science	14 May 2008	0
34	Development of Bioerodible Sustained Release Brimonidine Intraocular Device Hongshuang Guo, J. Chen, Grażyna Cynkowska et al. · Investigative Ophthalmology & Visual Science	17 Apr 2010	0
35	Sustained Release Celecoxib From Bioerodible Intraocular Devices J. Chen, Hongshuang Guo, Grażyna Cynkowska et al. · Investigative Ophthalmology & Visual Science	28 Apr 2009	0
36	Silicon Based Sustained Release Systems Paul Ashton, Huazhong Guo, J. Chen et al. · Investigative Ophthalmology & Visual Science	28 Apr 2009	0
37	Evaluation of a Single Intravitreal Injection of Extended Release Brimonidine Impregnated Device in a Rabbit Eye Sunil P. Deokule, Pippa Moss, M. Nazzaro et al. · Investigative Ophthalmology & Visual Science	17 Apr 2010	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.